These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 25810035)

  • 1. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.
    Sakakibara R; Panicker J; Finazzi-Agro E; Iacovelli V; Bruschini H;
    Neurourol Urodyn; 2016 Jun; 35(5):551-63. PubMed ID: 25810035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.
    Liu Z; Uchiyama T; Sakakibara R; Yamamoto T
    Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of bladder dysfunction in Parkinson's disease.
    Sakakibara R; Tateno F; Kishi M; Tsuyuzaki Y; Uchiyama T; Yamamoto T
    Neurobiol Dis; 2012 Jun; 46(3):565-71. PubMed ID: 22015601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder dysfunction in advanced Parkinson's disease.
    Winge K; Nielsen KK
    Neurourol Urodyn; 2012 Nov; 31(8):1279-83. PubMed ID: 22488851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract dysfunction in Parkinson's disease: a review.
    Yeo L; Singh R; Gundeti M; Barua JM; Masood J
    Int Urol Nephrol; 2012 Apr; 44(2):415-24. PubMed ID: 21553114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of lower urinary tract symptoms in patients with Parkinson's disease.
    Badri AV; Purohit RS; Skenazy J; Weiss JP; Blaivas JG
    Curr Urol Rep; 2014 Sep; 15(9):435. PubMed ID: 25002072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder function of patients with Parkinson's disease.
    Sakakibara R; Tateno F; Nagao T; Yamamoto T; Uchiyama T; Yamanishi T; Yano M; Kishi M; Tsuyusaki Y; Aiba Y
    Int J Urol; 2014 Jul; 21(7):638-46. PubMed ID: 24571321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.
    Sakakibara R; Tateno F; Yamamoto T; Uchiyama T; Yamanishi T
    Clin Auton Res; 2018 Feb; 28(1):83-101. PubMed ID: 29124503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and Management of Urinary Dysfunction in 187 Patients with Parkinson's Disease.
    Jia C; Cui X; Yoshimura N; Mao W; Xu E; Wang Q; Ou T
    J Parkinsons Dis; 2020; 10(3):993-1001. PubMed ID: 32310185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction.
    Xue P; Wang T; Zong H; Zhang Y
    Chin Med J (Engl); 2014; 127(5):878-81. PubMed ID: 24571881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
    Bonnet AM; Pichon J; Vidailhet M; Gouider-Khouja N; Robain G; Perrigot M; Agid Y
    Mov Disord; 1997 Jul; 12(4):509-13. PubMed ID: 9251068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters.
    Sammour ZM; Gomes CM; Barbosa ER; Lopes RI; Sallem FS; Trigo-Rocha FE; Bruschini H; Srougi M
    Neurourol Urodyn; 2009; 28(6):510-5. PubMed ID: 19191278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies.
    Brucker BM; Kalra S
    Urol Clin North Am; 2017 Aug; 44(3):415-428. PubMed ID: 28716322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson's disease.
    Zong H; Meng F; Zhang Y; Wei G; Zhao H
    Clin Interv Aging; 2019; 14():1159-1166. PubMed ID: 31417246
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives on the urological care in Parkinson's disease patients.
    Moussa M; Abou Chakra M; Papatsoris AG; Dellis A; Dabboucy B; Peyromaure M; Barry Delongchamps N; Bailly H; Duquesne I
    Arch Ital Urol Androl; 2022 Mar; 94(1):107-117. PubMed ID: 35352535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.
    Winge K; Fowler CJ
    Mov Disord; 2006 Jun; 21(6):737-45. PubMed ID: 16570299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy.
    Ogawa T; Sakakibara R; Kuno S; Ishizuka O; Kitta T; Yoshimura N
    Nat Rev Urol; 2017 Feb; 14(2):79-89. PubMed ID: 27958390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction.
    Van Batavia JP; Ahn JJ; Fast AM; Combs AJ; Glassberg KI
    J Urol; 2013 Oct; 190(4 Suppl):1495-9. PubMed ID: 23416636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.